Lorazepam challenge test: A unique clinical response in catatonia

Catatonia is a psychomotor behavioral syndrome characterized as a complex syndrome of bizarre motor behavior, impaired volition, and vegetative abnormalities. Catatonia is a medical emergency and if not recognized on time may have potentially fatal outcomes. We present a case series of three patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Seetharaman, Aparna, Chauhan, Vinay Singh, Adhvaryu, Arka, Prakash, Jyoti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611546/
https://www.ncbi.nlm.nih.gov/pubmed/34908697
http://dx.doi.org/10.4103/0972-6748.328871
_version_ 1784603313684086784
author Seetharaman, Aparna
Chauhan, Vinay Singh
Adhvaryu, Arka
Prakash, Jyoti
author_facet Seetharaman, Aparna
Chauhan, Vinay Singh
Adhvaryu, Arka
Prakash, Jyoti
author_sort Seetharaman, Aparna
collection PubMed
description Catatonia is a psychomotor behavioral syndrome characterized as a complex syndrome of bizarre motor behavior, impaired volition, and vegetative abnormalities. Catatonia is a medical emergency and if not recognized on time may have potentially fatal outcomes. We present a case series of three patients with catatonia, in whom Injection lorazepam 4 mg administered intravenously (Lorazepam Challenge) produced quick, optimum outcome.
format Online
Article
Text
id pubmed-8611546
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-86115462021-12-13 Lorazepam challenge test: A unique clinical response in catatonia Seetharaman, Aparna Chauhan, Vinay Singh Adhvaryu, Arka Prakash, Jyoti Ind Psychiatry J Case Series Catatonia is a psychomotor behavioral syndrome characterized as a complex syndrome of bizarre motor behavior, impaired volition, and vegetative abnormalities. Catatonia is a medical emergency and if not recognized on time may have potentially fatal outcomes. We present a case series of three patients with catatonia, in whom Injection lorazepam 4 mg administered intravenously (Lorazepam Challenge) produced quick, optimum outcome. Wolters Kluwer - Medknow 2021-10 2021-10-22 /pmc/articles/PMC8611546/ /pubmed/34908697 http://dx.doi.org/10.4103/0972-6748.328871 Text en Copyright: © 2021 Industrial Psychiatry Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Series
Seetharaman, Aparna
Chauhan, Vinay Singh
Adhvaryu, Arka
Prakash, Jyoti
Lorazepam challenge test: A unique clinical response in catatonia
title Lorazepam challenge test: A unique clinical response in catatonia
title_full Lorazepam challenge test: A unique clinical response in catatonia
title_fullStr Lorazepam challenge test: A unique clinical response in catatonia
title_full_unstemmed Lorazepam challenge test: A unique clinical response in catatonia
title_short Lorazepam challenge test: A unique clinical response in catatonia
title_sort lorazepam challenge test: a unique clinical response in catatonia
topic Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611546/
https://www.ncbi.nlm.nih.gov/pubmed/34908697
http://dx.doi.org/10.4103/0972-6748.328871
work_keys_str_mv AT seetharamanaparna lorazepamchallengetestauniqueclinicalresponseincatatonia
AT chauhanvinaysingh lorazepamchallengetestauniqueclinicalresponseincatatonia
AT adhvaryuarka lorazepamchallengetestauniqueclinicalresponseincatatonia
AT prakashjyoti lorazepamchallengetestauniqueclinicalresponseincatatonia

Ejemplares similares